MAPT and dementia: In the amyloid-positive dementia group, CSF t-tau levels kept increasing (β [SE] = 24.97 [7.80] pg/mL per year; P = .002), but this was not observed for p-tau (β [SE] = 1.95 [1.17] pg/mL; P = .10).